Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).

Erwin Woff,Pashalina Kehagias,Caroline Vandeputte,Tarek Kamoun,Thomas Guiot,Lieveke Ameye,Karen Geboes,Thierry Delaunoit,Gauthier Demolin,Marc Peeters,Lionel A. DHondt,Jos Janssens,Javier Carrasco,Stéphane Holbrechts,Jean-Charles Goeminne,Jean-Luc Van Laethem,Philippe Vergauwe,Marianne Paesmans,Patrick Flamen,Alain Hendlisz

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).

2017

11569Background: No validated prognostic biomarker is currently available for mCRC. This trial assessed cfDNA and MTV before treatment with regorafenib as prognostic biomarkers for progression-free...

Keywords:

Cell-free fetal DNA
Pathology
Colorectal cancer
Cancer research
Medicine
metabolic tumor volume
Regorafenib
Oncology
prognostic biomarker
Internal medicine
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations